Clinical Trial Update: Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of EN3324 (Axomadol) in chronic low back pain has completed, summarizing efficacy signals and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Axomadol (EN3324)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Chronic Low Back Pain | Phase 2 | Status: COMPLETED